张弘 张春玲 徐德祥 孙荣丽 陈霞.肺炎克雷伯杆菌对抗菌药物耐药性变化的影响[J].,2015,15(2):328-331 |
肺炎克雷伯杆菌对抗菌药物耐药性变化的影响 |
A Study on the Antimicrobial Resistance Change of Klebsiella Pneumoniae |
|
DOI: |
中文关键词: 蒙特卡罗模拟 肺炎克雷伯杆菌 抗菌药物 耐药性 |
英文关键词: Monte Carlo simulation Klebsiella pneumoiae Antimicrobial drug Drug resistance |
基金项目:青岛市公共领域科技支撑项目(2012-1-3-4-(3)-
nsh) |
|
摘要点击次数: 913 |
全文下载次数: 1090 |
中文摘要: |
目的:监测几种临床常用抗菌药物对肺炎克雷伯杆菌最低抑菌浓度(MIC)变化情况,在临床工作中帮助选择合理的初始化
抗菌治疗方案。方法:本研究选择哌拉西林他唑巴坦、头孢哌酮舒巴坦、拉氧头孢钠、左氧氟沙星及头孢他啶5 种常用的抗革兰
氏阴性杆菌感染的治疗药物作为初始经验性治疗方案,使用随机法将5 种抗菌方案分配到5 个观察组,5 个观察组于
2011.07-2012.07 间各自采集HAP 患者痰标本,筛选出其中ESBLs(-)肺炎克雷伯杆菌资料,并于2012.08-2013.08 间分别使用1
种拟定的抗菌治疗方案进行HAP的初始化治疗。使用Crystal Ball 软件进行蒙特卡罗模拟计算上述5 种药物常用方案的两个阶
段的累计反应分数(CFR),比较其效果。结果:(1)在按规定方案治疗1 年后,头孢哌酮钠舒巴坦、哌拉西林他唑巴坦、拉氧头孢
钠、左氧氟沙星组有效率改变均无统计学意义,头孢他啶组固定初始化治疗1 年后有效率下降,有统计学意义(P=0.037);(2 )对各
科室初始化方案再次进行了蒙特卡罗模拟,对比后发现头孢他啶方案CFR 较前下降明显,其余方案CFR 差异小。结论:蒙特卡
罗模拟法可计算出用药方案达到药效学指标的概率,以CFR 为标准可以更为直观的选择经验性治疗方案,并有效的监测细菌耐
药性的变化。 |
英文摘要: |
Objective:Monitoring Minimum inhibitory concentration (MIC)changes of Klebsiella pneumoniae of several
antimicrobial agents which commonly used in clinical, to help making a reasonable choice of initializing antimicrobial treatment
programs in clinical work.Methods:In this study, piperacillin-tazobactam, cefoperazone sulbactam, Latamoxef sodium, levofloxacin and
ceftazidime five kinds of commonly used anti-Gram-negative bacilli infections drugs as initial empiric therapy, were assigned to five
observation groups by random method.Collected sputum samples of patients with HAP in each observation group at 2011.07-2012.07,
then screened out of which ESBLs (-) Klebsiella pneumoniae data and used one intended antimicrobial initialization treatment of HAP
Respectively at 2012.08-2013.08. Using Crystal Ball software for Monte Carlo calculation of two-stage CFR of the above five kinds of
drugs commonly used programs, and their results were compared.Results:(1) One year later, treatment efficiency in cefoperazone
sulbactam group, piperacillin-tazobactam group, Latamoxef sodium group and levofloxacin group was not statistically significantly
changed, while its decrease was statistically significant in ceftazidime group (P = 0.037). (2) Compared the CFR of two stages and found
that of ceftazidime significantly decreased compared with the previous CFR, and others had small differences.Conclusion:Monte Carlo
simulation calculates the probability of drug regimens to achieve pharmacodynamic targets. With the CFR as a standard , empiric
treatment programs can be selected more visually, and change of bacterial resistance can be monitored effectively. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |
|
|
|